Stevanato Group Corp (STVN): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Stevanato (STVN)

Stevanato Group S.p.A. (STVN) dominates the precision glass segment for complex drugs. The Italian brand blends a family-run approach with stringent pharmaceutical regulations. Patent protection and an extensive infrastructure enable the company to maintain high profitability. The P/S multiple trend illustrates the correlation between market capitalization and revenue, while 0.50 shows the current value of the metric at this stage.

Price-to-Revenue Ratio: Stevanato Group (STVN) for 07/04/2022 - 11/14/2026

Metric breakdowns and analytics for Stevanato (STVN)

- stock quotes and analyst forecast:
Price stevanatogroup.com|STVN - Price Target Chart
- stock exchange capitalization data:
Market Value Stevanato|STVN - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Value per Share Stevanato Group|STVN - Company Book Value|Market Cap to Net Assets Ratio stevanatogroup.com|STVN - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Stevanato Group S.p.A.|STVN - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Stevanato Group Corp|STVN - Company Total Debt|Debt to Book Capital Stevanato|STVN - Company Long-Term Debt|Short-Term Debt Volume Stevanato Group|Interim Coverage Ratio stevanatogroup.com
- company profitability and valuation multiples indicators:
STVN - Net Income|Future Net Profit Stevanato Group S.p.A.|STVN - P/E Multiple|Projected Price to Earnings Ratio Stevanato Group SpA|STVN - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stevanato|STVN - Operating profit EBITDA|Net earnings per share (EPS TTM) Stevanato Group|STVN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months stevanatogroup.com|STVN - Earnings growth in current year|Earnings growth forecast for next year Stevanato Group S.p.A.
- total revenue and sales volume data:
STVN - Company Sales|Company Projected Revenue Volume stevanatogroup.com|STVN - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio Stevanato
Summary company analytics:stevanatogroup.com
Mass-produced product of stevanatogroup.com

To identify undervalued assets, it is essential for an investor to compare market capitalization with sales volume to determine the fair value of a business relative to its revenue. Analyzing this ratio helps identify the risk of overpayment during revenue declines, which is particularly relevant for Stevanato Group S.p.A. (STVN) during the costly electrification of furnaces; therefore, the boundaries of a sustainable valuation corridor should be monitored via the P/S chart.

Competitors of Stevanato Group S.p.A.

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue masimo.com|TFX (Teleflex) - P/S Multiple|Price to Sales Merit Medical Systems, Inc. MMSI|Price-to-Revenue Ratio Envista Holdings Corp (NVST)|ICU Medical Inc. - Market Cap to Revenue Ratio|DENTSPLY SIRONA Inc. - Market Cap to Revenue|Market Cap to Sales Volume LMAT (lemaitre.com)|ATRC - Price-to-Revenue Ratio|Price-to-Revenue Coefficient STAAR Surgical Co. STAA|ChromaDex Corp (NAGE) - Price-to-Revenue Ratio|ZIMV - Price-to-Revenue Coefficient|Market Cap to Revenue ANGO|CERS (cerus.com) - Market Cap to Sales Volume|P/S Multiple TKNO|MGRM - Price to Sales|Sharps Technology - Market Cap to Revenue|InfuSystem - Price-to-Revenue Ratio|Utah Medical Products - P/S Multiple|KRMD - P/S Multiple|Nyxoah (NYXH) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio MBOT|PDEX (Pro-Dex Corp) - P/S Multiple|P/S Multiple Zentek Corp|Market Cap to Revenue ELUT (Elutia Inc.)|Market Cap to Sales Volume MLSS|Price-to-Revenue Ratio NEXGEL NXGL|Retractable Technologies Inc. (RVP) - Price to Sales|HBIO: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio FEMY (Femasys Corporation)|MHUA: P/S Multiple|Price-to-Revenue Multiple Predictive Oncology Inc. POAI|Price-to-Revenue Ratio Callan JMB Inc.|ATRI: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio NeuroMetrix Corp (NURO)